The Use of MitraClip in Secondary Mitral Regurgitation and Heart Failure
- 19 May 2020
- journal article
- review article
- Published by Elsevier BV in Cardiovascular Revascularization Medicine
- Vol. 21 (12), 1606-1612
- https://doi.org/10.1016/j.carrev.2020.05.015
Abstract
No abstract availableKeywords
Funding Information
- Abbott Vascular
This publication has 76 references indexed in Scilit:
- Percutaneous Mitral Valve Interventions in the Real World: Early and 1-Year Results From the ACCESS-EU, A Prospective, Multicenter, Nonrandomized Post-Approval Study of the MitraClip Therapy in EuropeJournal of the American College of Cardiology, 2013
- Etiology of Valvular Heart Disease in the 21st CenturyCardiology, 2013
- Real‐Time 3‐Dimensional Dynamics of Functional Mitral Regurgitation: A Prospective Quantitative and Mechanistic StudyJournal of the American Heart Association, 2013
- Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk StudyJournal of the American College of Cardiology, 2012
- Cardiac Resynchronization Therapy as a Therapeutic Option in Patients With Moderate-Severe Functional Mitral Regurgitation and High Operative RiskCirculation, 2011
- Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatmentEuropean Heart Journal, 2010
- Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart FailureJAMA, 2009
- Cardiac Resynchronization TherapyProgress in Cardiovascular Diseases, 2006
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999